In a comparison of VIP concentrations in different metastatic GIT cancers (gastric, pancreatic and CRC), significantly higher levels of this peptide were detected in CRC in relation to both gastric [237] and pancreatic cancers [158]. The gene discussed is VIP; the disease is colorectal carcinoma.